Germany Pneumococcal Vaccines Market , Forecasts to 2033

The Germany Pneumococcal Vaccines Market is anticipated to exceed USD 240.5 Million by 2033, growing at a CAGR of 2.36% from 2023 to 2033. The growing prevalence of pneumonia and a strong pipeline for pneumococcal vaccines are driving the growth of the pneumococcal vaccines market in Germany. Pneumococcal vaccines are a pharmacologic compound that improves a person’s immunity to a pneumococcal disease, which is any type of illness caused by Streptococcus pneumoniae bacteria.